Incorporating Molecular Testing to Support Personalized Cancer Care

PI header image bar

Incorporating Molecular Testing to Support Personalized Cancer Care

Activity graphicMolecular testing is a foundational element of personalized medicine. Understanding and overcoming challenges in implementing best practice guidelines for molecular testing can support better diagnosis and guide treatment decisions. “Incorporating Molecular Testing to Support Personalized Cancer Care” is a three-part educational program that focuses on the adoption of best practice guidelines and incorporating evidence from an MD Anderson Cancer NetworkTM Performance Improvement and Quality Improvement (PI/QI) program (a program of The University of Texas MD Anderson Cancer Center). Piloted at two Cancer Network sites, this PI/QI program aimed to optimize the use of molecular testing in thyroid and lung cancers

“Incorporating Molecular Testing to Support Personalized Cancer Care” is designed specifically for oncologists and other multidisciplinary healthcare team members who are part of community-based cancer centers across the United States, with the goal of improving molecular testing practices and enhancing personalized care by implementing PI and QI interventions. Dr. Ecaterina Dumbrava, an oncologist at MD Anderson is the principal investigator and lead faculty for this program. She is also the presenter for the activities, along with Sophie Péloquin, MMedSc, Vice-President of AXDEV Group, an organization specializing in PI/QI and educational and implementation research in healthcare.

The Society for Translational Oncology designates these enduring materials for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Activity 1 banner

Activity 1 – The Power of Precision: Molecular Testing for Personalized Cancer Care
Dr. Dumbrava briefly describes personalized medicine and reviews some of the key NCCN guideline recommendations for molecular testing in thyroid and non-small cell lung cancers using cases from the PI/QI program.


Activity 2 – Breaking Down Molecular Testing for Patients: Communication Essentials
Dr. Dumbrava stresses the vital role of patients’ understanding of molecular testing for informed shared decision-making in personalized cancer care. Through simulated patient-provider conversations, she offers valuable suggestions and examples to enhance communication with patients and their families during discussions about molecular testing.

Activity 3 – Molecular Testing in Practice: Introducing Performance and Quality Improvement
Péloquin outlines a three-step process for implementing effective PI or QI interventions. The process includes the Diagnostic Phase, focusing on identifying local needs and challenges, followed by the Planning and Implementation Phase. The final step is the Evaluation Phase, involving tracking progress and measuring impact. Dr. Dumbrava explains how PI/QI concepts were applied in the Cancer Network PI/QI program.

Toolkit icon

A toolkit of references and resources that reinforce and expand upon the education, including updated guidelines, patient communication strategies, and foundational education about PI and QI, is provided.

A live Q&A session is scheduled for May 2024 to allow learners to engage with the faculty to discuss questions about real world application and implementation of PI and QI in clinical practice.

Program Faculty

Image of Ecaterina Dumbrava

Ecaterina (Cathy) Dumbrava, MD

Department of Investigational Cancer Therapeutics,
Division of Cancer Medicine, MD Anderson

Sophie headshot

Sophie Péloquin, MMedSc

Vice-President of AXDEV Group

These activities are hosted on Healio. If you do not have a Healio account, you may register for a free account.

Brought to you by the Society for Translational Oncology, in collaboration with AXDEV Global and MD Anderson Cancer Network™, a program of The University of Texas MD Anderson Cancer Center.

The Society for Translational Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

These activities are supported by an educational grant from Lilly.